Open AccessShould Patients With NAFLD/NASH Be Surveyed for HCC?
Author(s) -
María Reig,
Martina Gambato,
Nancy Kwan Man,
John P. Roberts,
David W. Victor,
Lorenzo A. Orci,
Christian Toso
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002361
Subject(s) - medicine , cirrhosis , hepatocellular carcinoma , incidence (geometry) , nonalcoholic fatty liver disease , gastroenterology , retrospective cohort study , prospective cohort study , fatty liver , disease , physics , optics
Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance strategy.